Are There Any Clinical Trials Involving STAT3 Inhibitors?
Yes, several clinical trials are currently evaluating the efficacy of STAT3 inhibitors in various cancers. For example, TTI-101 is a small molecule STAT3 inhibitor that is being tested in advanced solid tumors. Another promising compound, OPB-51602, has shown activity in hematologic malignancies.
